AnidulafunginImmuneSafety Rating 8/10
Primary research areaInvasive candidiasis
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range200 mg IV loading then 100 mg daily
AdministrationIntravenous
Safety8/10 · FDA-approved (Eraxis)
NCAA D1Permitted
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Anidulafungin
Mechanism of action
Echinocandin antifungal; non-competitive beta-1,3-glucan synthesis inhibitor unique chemical structure
Safety profile
Hepatitis risk, rash, GI symptoms, histamine-like reactions · Well-established IV antifungal; rare hepatotoxicity; generally well-tolerated
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Anidulafungin below your target.
Related pages